Sandy Spring Bank’s Antares Pharma, Inc. ATRS Stock Holding History

Sandy Spring Bank’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,000	Closed	-$3K	–	1003
2020 Q2	$3K	Hold	1,000	–	–	﹤0.01%	816
2020 Q1	$2K	Hold	1,000	–	–	﹤0.01%	844
2019 Q4	$5K	Sell	1,000 -1,000	-50%	-$4.09K	﹤0.01%	778
2019 Q3	$7K	Sell	2,000 -3,000	-60%	-$9.88K	﹤0.01%	764
2019 Q2	$16K	Buy	+5,000	New	+$14.5K	﹤0.01%	657

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sandy Spring Bank's ATRS Position: Q3 2020 in Review

Sandy Spring Bank sold out of Antares Pharma, Inc. (ATRS) in Q3 2020, closing a stake of 1,000 shares — an estimated $3K sold.

Sandy Spring Bank first reported a position in ATRS in Q2 2019 and held it in 5 quarters. The position peaked at $16K in Q2 2019. 164 funds tracked by Wall St. Rank hold ATRS as of Q3 2020.

Sandy Spring Bank reported no remaining Antares Pharma, Inc. position as of Q3 2020 after selling out during the quarter.
Sandy Spring Bank sold 1,000 Antares Pharma, Inc. shares in Q3 2020, an estimated $3K.
Sandy Spring Bank first reported a position in Antares Pharma, Inc. in Q2 2019 and held it in 5 quarters.
Sandy Spring Bank's Antares Pharma, Inc. position peaked at $16K in Q2 2019.
164 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2020.

Based on Sandy Spring Bank's 13F filing for Q3 2020, filed 9 Nov 2020.